Adults who lost weight with once-weekly injectable semaglutide or tirzepatide were able to maintain more than 70% of their ...

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature Medicine shows that most weight loss achieved using the injectable obesity ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Swiss pharma giant Roche won approval from the ...

Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for ...

An experimental Metsera obesity drug led to an average 8.4% weight loss in a small clinical trial, preliminary results that keep the biotech competitive in the crowded mix of companies pursuing a ...

A GLP-1 Bridge pilot program launching in July can significantly reduce the price you pay for weight loss meds. Here’s how to ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder treatment, recently introduced injectable medications as a new treatment ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...

This article was reviewed by Kelly Brown MD, MBA. For men who don’t respond to oral ED medications like Viagra, Trimix injections can be a game-changer. It’s an injectable ED medication you insert ...